Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AGC Biologics
Manufacturing
FDA slams Eugia with Form 483 and posts several other reprimands
Aurobindo subsidiary Eugia US received an FDA Form 483 write-up following an inspection that turned up 10 observations at the company’s NJ facility.
Joseph Keenan
Jan 31, 2024 4:30pm
Growing AGC reveals plan for second manufacturing site in Japan
Jan 4, 2024 9:00am
AGC beefs up Colorado cell and gene therapy production facility
Aug 23, 2023 6:00am
AGC finishes expansion of gene therapy facility in Italy
Aug 9, 2023 8:10am
AGC Biologics tapped to produce long-awaited diabetes drug
Jan 25, 2023 10:33am
AGC Biologics expands capacity at Heidelberg plant
Sep 21, 2021 9:45am